July 31, 2026 · The Nurse practitioner · DOI: 10.1097/01.NPR.0000000000000460

The Drug Update: Recent drug approvals, summer 2026 edition

Listen to this summary

This article reviews recent drug approvals by the US Food and Drug Administration in the latter half of 2025, focusing on medications relevant to primary care practitioners. It highlights new drugs such as brensocatib, elinzanetant, and zoliflodacin, as well as new indications for existing therapies like finerenone for heart failure and cyclobenzaprine for fibromyalgia. The authors aim to inform healthcare providers about these updates to enhance patient care.

Madison T Treadway, Adriane B Marino, Jenna D Theroux, Evan S Drake

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play